Theoretical review: altered pain regulatory systems in chronic pain (Q33762802)

29 July 2017

1 reference

title

Theoretical review: altered pain regulatory systems in chronic pain (English)

1 reference

29 July 2017

0 references

Bruehl S

1

1 reference

29 July 2017

McCubbin JA

series ordinal

2

1 reference

29 July 2017

Harden RN

series ordinal

3

1 reference

29 July 2017

publication date

1 January 1999

1 reference

Neuroscience & Biobehavioral Reviews

29 July 2017

published in

1 reference

29 July 2017

volume

23

1 reference

29 July 2017

issue

6

1 reference

29 July 2017

page(s)

877-890

1 reference

Synopsis: Workshop on Idiopathic Low-Back Pain

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Hypertension-associated hypalgesia. Evidence in experimental animals and humans, pathophysiological mechanisms, and potential clinical consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Hypertension-induced analgesia: changes in pain sensitivity in experimental hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Altered pain perception in hypertensive humans

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

The relationship between pain sensitivity and blood pressure in normotensives

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Do endogenous opioids mediate the relationship between blood pressure and pain sensitivity in normotensives?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Endogenous opiate peptides, stress reactivity, and risk for hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Opioid dysfunction and risk for hypertension: naloxone and blood pressure responses during different types of stress

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Multiple opioid systems and pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Endorphins in chronic pain. I. Differences in CSF endorphin levels between organic and psychogenic pain syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Alpha-1-acid Glycoprotein and Beta-endorphin Alterations in Chronic Pain Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Naloxone in moderate dose does not aggravate chronic tension headache

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Are the endorphins active in clinical pain states? Narcotic antagonism in chronic pain patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Genetic predisposition to hypertension, elevated blood pressure and pain sensitivity: a functional analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Factors influencing the altered pain perception in the spontaneously hypertensive rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Spontaneously (genetic) hypertensive rats: naloxone-reversible and propranolol-reversible decrease in pain sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Naloxone reversible decrease in pain sensitivity in young and adult spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Hypoalgesia in genetically hypertensive rats (SHR) is absent in rats with experimental hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Acute increases in arterial blood pressure produced by occlusion of the abdominal aorta induces antinociception: peripheral and central substrates

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Association between hypoalgesia and hypertension in rats after short-term isolation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Arterial hypertension is associated with hypalgesia in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Effects of PRES baroreceptor stimulation on thermal and mechanical pain threshold in borderline hypertensives and normotensives

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Comparison of pain perception in normotensives and borderline hypertensives by means of a tooth pulp-stimulation test

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

The influence of resting blood pressure and gender on pain responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Resting blood pressure and thermal pain responses among females: effects on pain unpleasantness but not pain intensity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Twenty-four-hour noninvasive blood pressure monitoring and pain perception

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Pain perception and cardiovascular responses in men with positive parental history for hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Pain sensitivity in offspring of hypertensives at rest and during baroreflex stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Parental history of hypertension and enhanced cardiovascular reactivity are associated with decreased pain ratings

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Baroreceptor activation reduces reactivity to noxious stimulation: implications for hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

The role of sinoaortic and cardiopulmonary baroreceptor reflex arcs in nociception and stress-induced analgesia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Sympathetic tonus and cortical electrical activity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Central effects of baroreceptor activation in humans: attenuation of skeletal reflexes and pain perception

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Baroreceptor stimulation alters pain sensation depending on tonic blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Baroreceptor cortical effects, emotions and pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

A possible interface between autonomic function and pain control: opioid analgesia and the nucleus tractus solitarius

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

The relationship between cardiovascular and pain regulatory systems

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Antinociception and cardiovascular responses produced by electrical stimulation in the nucleus tractus solitarius, nucleus reticularis ventralis, and the caudal medulla

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Release of beta-endorphin and methionine-enkephalin into cerebrospinal fluid during deep brain stimulation for chronic pain. Effects of stimulation locus and site of sampling

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Interactions between cardiovascular and pain regulatory systems

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Antinociception and cardiovascular responses produced by intravenous morphine: the role of vagal afferents

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Pain sensitivity and opioid activity in genetically and experimentally hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Observations on pain perception and hypertension in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Relation between systemic hypertension and pain perception

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Relationship between pain sensitivity, cardiovascular reactivity to cold pressor test and indexes of activity of the adrenergic and opioid system

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Release of neurotransmitters in the locus coeruleus.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Systemic administration of beta-endorphin: potent hypotensive effect involving a serotonergic pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Endogenous Opioids in Cerebrospinal Fluid and Blood in Idiopathic Headache Sufferers

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Plasma measures of beta-endorphin/beta-lipotropin-like immunoreactivity in chronic pain syndrome and psychiatric subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Plasma endorphin-like immunoreactivity in pelvic and abdominal pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

CSF beta-endorphin and the severity of pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

CSF monoamine metabolites in chronic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Pain Relief by Electrical Stimulation of the Central Gray Matter in Humans and Its Reversal by Naloxone

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Predictors for the outcome of treatment with high frequency transcutaneous electrical nerve stimulation in patients with chronic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Personality traits in chronic pain patients related to endorphin levels in cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Acupuncture relief of chronic pain syndrome correlates with increased plasma met-enkephalin concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Peak B endorphin concentration in cerebrospinal fluid: reduced in chronic pain patients and increased during the placebo response

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Plasma opioid levels in post-traumatic chronic headache and trigeminal neuralgia: maintained response to acupuncture

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

CSF β-EP in Headache and Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Endorphin levels in cerebrospinal fluid of patients with postoperative and chronic pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Evaluation of beta-endorphin/beta-lipotropin immunoreactivity content in the CSF of patients affected by deafferentation pain syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Simultaneous determination of radio-immunoassayable methionine-enkephalin and radioreceptor-active opiate peptides in CSF of chronic pain suffering and non suffering patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Pain perception and endorphin levels in cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Partial characterization of a novel endogenous opioid in human cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Interactions between the neuroendocrine and immune systems: common hormones and receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Non-opioid pathways suppress pain in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Dextromethorphan potentiates the effect of morphine in rats with peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Spinally administered dynorphin A produces long-lasting allodynia: involvement of NMDA but not opioid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Prodynorphin gene expression is enhanced in the spinal cord of chronic arthritic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Progressive impairment of CSF β-EP levels in migraine sufferers

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

A model of chronic pain in the rat: response of multiple opioid systems to adjuvant-induced arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Combined high-performance liquid chromatographic-radioimmunoassay method for the analysis of endorphins, enkephalins and other neurotransmitter peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

The narcotic antagonist naloxone enhances clinical pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Psychological coping with acute pain: an examination of the role of endogenous opioid mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

The effects of myofascial trigger point injections are naloxone reversible

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

The influence of naloxone on analgesia produced by peripheral conditioning stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Naloxone fails to reverse hypnotic alleviation of chronic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Relationship between pain sensitivity and resting arterial blood pressure in patients with painful temporomandibular disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Hyperalgesia or hypervigilance? An evoked potential approach to the study of fibromyalgia syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Stress-induced alterations in the levels of messenger RNA coding for proopiomelanocortin and prolactin in rat pituitary

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Persistence behavior of chronic low back pain patients in an acute pain situation.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Chronic low back pain and the reaction to repeated acute pain stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Stress-induced analgesia in humans: endogenous opioids and naloxone-reversible depression of pain reflexes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Pain sensitivity in patients with temporomandibular disorders: relationship to clinical and psychosocial factors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

The assessment of pain and plasma beta-endorphin immunoactivity in burned children

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Altered cardiovascular/pain regulatory relationships in chronic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

A controlled study of the effects of a supervised cardiovascular fitness training program on the manifestations of primary fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Aerobic fitness and opioidergic inhibition of cardiovascular stress reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Coping styles, opioid blockade, and cardiovascular response to stress

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

Relaxation training and opioid inhibition of blood pressure response to stress

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2899%2900039-1

7 January 2021

10.1016/S0149-7634(99)00039-1

Identifiers

DOI

1 reference

29 July 2017

1 reference